IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $35,072,000 | -65.9% | 3,176,773 | -48.6% | 0.19% | -61.5% |
| Q1 2022 | $102,820,000 | -11.1% | 6,175,357 | +1.9% | 0.50% | -14.2% |
| Q4 2021 | $115,723,000 | -12.1% | 6,061,973 | +13.5% | 0.58% | -6.0% |
| Q3 2021 | $131,684,000 | -3.6% | 5,339,994 | +1.7% | 0.62% | +10.2% |
| Q2 2021 | $136,605,000 | -9.2% | 5,250,000 | +10.5% | 0.56% | -25.3% |
| Q1 2021 | $150,385,000 | -46.0% | 4,750,000 | -20.8% | 0.75% | -55.4% |
| Q4 2020 | $278,400,000 | +42.0% | 6,000,000 | +0.8% | 1.67% | +23.5% |
| Q3 2020 | $196,039,000 | +9.2% | 5,955,000 | -8.9% | 1.36% | -5.6% |
| Q2 2020 | $179,454,000 | +4.3% | 6,537,500 | +13.7% | 1.44% | -2.8% |
| Q1 2020 | $172,126,000 | -0.5% | 5,750,000 | -8.0% | 1.48% | +26.5% |
| Q4 2019 | $173,000,000 | +57.8% | 6,250,000 | +3.7% | 1.17% | +41.1% |
| Q3 2019 | $109,655,000 | -21.9% | 6,025,000 | +5.2% | 0.83% | -9.3% |
| Q2 2019 | $140,377,000 | +157.8% | 5,725,000 | 0.0% | 0.91% | +123.2% |
| Q1 2019 | $54,445,000 | +7.5% | 5,725,000 | 0.0% | 0.41% | +10.2% |
| Q4 2018 | $50,666,000 | -4.7% | 5,725,000 | +21.2% | 0.37% | +18.2% |
| Q3 2018 | $53,156,000 | -6.2% | 4,725,000 | +6.8% | 0.31% | -10.3% |
| Q2 2018 | $56,640,000 | -19.2% | 4,425,000 | +6.6% | 0.35% | -28.0% |
| Q1 2018 | $70,135,000 | +369.6% | 4,150,000 | +122.3% | 0.49% | +301.7% |
| Q4 2017 | $14,935,000 | +126.7% | 1,866,900 | +119.6% | 0.12% | +105.1% |
| Q3 2017 | $6,588,000 | – | 850,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |